iMediSync
PrivateLast Round
Series C
Nov 30, 2021
Total Funding Raised
$15.84M
Company Overview
iMediSync operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series C round in November 2021.
iMediSync is a digital health company that provides an AI-based platform for mental healthcare, including EEG/HRV measurement devices and analysis software.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Subscription SaaS, Usage-Based SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iMediSync Comparables
Compare iMediSync with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zeto, Inc. | 87% | |
| Firefly Neuroscience, Inc. | 79% | |
| Advanced Brain Monitoring Inc. | 77% |
For institutional investors. Book with your work email.
iMediSync Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 30, 2021 | ||||
| Grant | Jul 25, 2020 | ||||
| Series B | Apr 7, 2020 | ||||
| Series A | Jun 1, 2018 |
For institutional investors. Book with your work email.
iMediSync Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| A Ventures | Series B |
| NHN Investment | Series A |
| Ministry of Trade, Industry and Energy | Grant |
| Korea Development Bank | Series B |
| Government of South Korea | Grant, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 17, 2025
Grew 33% QoQ from 9 to 12 employees.
- Nov 30, 2021
Raised $6.4M in Series C funding.
For institutional investors. Book with your work email.
iMediSync Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about iMediSync's valuation, stock price, and market status.
Is iMediSync a public or private company?
iMediSync is a private company.
What is the current stock price of iMediSync?
iMediSync is a private company, so its shares have no public market price. Caplight tracks iMediSync's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is iMediSync worth (valuation)?
Valuation information for iMediSync is not publicly available.
Can I buy iMediSync stock?
iMediSync shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was iMediSync's last funding round?
iMediSync's most recent funding round was Series C on November 30, 2021.
Who are the main investors in iMediSync?
Key investors in iMediSync include Korea Development Bank.
Will iMediSync IPO soon?
No public IPO plans have been announced for iMediSync.
How can I track iMediSync secondary market activity?
Caplight tracks bids, offers, and trades in iMediSync's shares on secondary markets.